Scale market report: 2G Energy AG is the top seller

2G: high turnover, many recommendations

The most traded Scale share on the marketplaces of Deutsche Börse in 2024 was 2G Energy with a turnover of EUR 114 million. It was followed by Datagroup (98 million), Formycon (83 million), Mensch und Maschine (74 million) and Deutsche Rohstoff (74 million). Also heavily traded: Cliq Digital, Verve Group, Vectron Systems, Ernst Russ and Nabaltec.

The share price of 2G (DE000A0HL8N9) experienced ups and downs in 2024; in the new year, the large heat pump and combined heat and power plant manufacturer is currently trading at EUR 25.35. The share is often recommended as a green investment and is also well received by analysts. Warburg Research (target price EUR 39), SMC Research (EUR 35), First Berlin (EUR 34) and Metzler Capital Markets (EUR 31.90) have all issued buy recommendations.

The shares of oil producer Deutsche Rohstoff (DE000A0XYG76), which is also heavily traded, also fluctuated sharply in 2024. This year, it has risen to EUR 35.50 with higher oil prices. Analysts' opinions differ here: First Berlin and mwb Research recommend buying (price targets 48 and 50.40 euros), Kepler Cheuvreux recommends reducing (price target 30 euros). 

New anchor shareholder for MPC 

MPC Capital (DE000A1TNWJ4), one of the top performers, announced a new majority shareholder in December: the Greek entrepreneur Petros Panagiotidis, who comes from the shipping industry. Montega subsequently downgraded its recommendation from buy to hold, with a target price of EUR 6.50 - albeit down to EUR 6.40 due to the strong share price performance. The share price level almost entirely reflects the company's performance as forecast by Montega. MPC is now trading at 5.55 euros again. 

Cantourage: Good figures, poor share price performance

Cantourage (DE000A3DSV01) continues to have a bumpy ride on the stock market. On Tuesday of this week, the provider of medical cannabis reported revenues of 51.4 million euros for the full year 2024 - more than forecast (46 to 50 million) and an increase of 118 percent compared to the previous year. Shortly before Christmas, Cantourage also announced a new collaboration with the Polish pharmaceutical wholesaler PharmaVitae.

The analyst firm Nuways then confirmed its buy recommendation with a current target price of 12 euros, which would be more than double the current price of 4.86 euros. Although the Polish market for medical cannabis is still at an early stage, the regulatory framework is improving. Nuways also believes that the risks posed by the probable change of government in Germany are low due to the company's focus on medical cannabis. 

Former Scale member now in the TecDAX

Former Scale member Formycon (DE000A1EWVY8) - listed in the Prime Standard since November 2024 - has not only been a member of the SDAX but also the TecDAX since the beginning of this week. The provider of follow-on products for biopharmaceutical drugs (biosimilars) is therefore one of the 30 largest listed technology companies in Germany in terms of market capitalization and trading volume. This share is also extremely popular with analyst firms. Formycon itself lists eleven analyst firms that rate the share - all with buy recommendations. Examples include Berenberg (target price EUR 102), First Berlin (EUR 82), Hauck & Aufhäuser (EUR 90), B. Metzler (EUR 82), Oddo BHF (EUR 80) and M.M. Warburg (EUR 93). The share price currently stands at 61.70 euros.  

By Anna-Maria Borse © 15 January, 2025, Deutsche Börse AG